Ontology highlight
ABSTRACT:
SUBMITTER: Lejeune J
PROVIDER: S-EPMC3502245 | biostudies-other | 2012 Nov-Dec
REPOSITORIES: biostudies-other
Lejeune Julien J Piègu Benoît B Gouilleux-Gruart Valérie V Ohresser Marc M Watier Hervé H Thibault Gilles G
mAbs 20121002 6
The FCGR3A-V158F and FCGR2A-H131R polymorphisms are associated with clinical responses to therapeutic mAbs and with immune thrombocytopenic purpura (ITP). The FCGR2C-ORF/STOP polymorphism, controlling FcγRIIC expression on natural killer cells and therefore FcγRIIC-mediated antibody dependent cell-mediated cytotoxicity, is also associated with ITP. Using a new pyrosequencing assay to determine this polymorphism in a control population, we observed the expected allele frequencies (ORF:12.6%) and ...[more]